336 related articles for article (PubMed ID: 26588476)
1. Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule.
Portale AA; Zhang MY; David V; Martin A; Jiao Y; Gu W; Perwad F
PLoS One; 2015; 10(11):e0142924. PubMed ID: 26588476
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice.
Tomoe Y; Segawa H; Shiozawa K; Kaneko I; Tominaga R; Hanabusa E; Aranami F; Furutani J; Kuwahara S; Tatsumi S; Matsumoto M; Ito M; Miyamoto K
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1341-50. PubMed ID: 20357029
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice.
Martins JS; Liu ES; Sneddon WB; Friedman PA; Demay MB
Endocrinology; 2019 Oct; 160(10):2204-2214. PubMed ID: 31237611
[TBL] [Abstract][Full Text] [Related]
5. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808
[TBL] [Abstract][Full Text] [Related]
6. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M
Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513
[TBL] [Abstract][Full Text] [Related]
7. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278
[TBL] [Abstract][Full Text] [Related]
8. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.
Küng CJ; Haykir B; Schnitzbauer U; Egli-Spichtig D; Hernando N; Wagner CA
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F785-F798. PubMed ID: 34719948
[TBL] [Abstract][Full Text] [Related]
10. [Renal hypophosphatemia:pathophysiology and treatment].
Sekine T
Clin Calcium; 2016 Feb; 26(2):284-94. PubMed ID: 26813509
[TBL] [Abstract][Full Text] [Related]
11. Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation.
Farrow EG; Summers LJ; Schiavi SC; McCormick JA; Ellison DH; White KE
J Endocrinol; 2010 Oct; 207(1):67-75. PubMed ID: 20675303
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.
Marsell R; Krajisnik T; Göransson H; Ohlsson C; Ljunggren O; Larsson TE; Jonsson KB
Nephrol Dial Transplant; 2008 Mar; 23(3):827-33. PubMed ID: 17911089
[TBL] [Abstract][Full Text] [Related]
13. Hypophosphatemia in vitamin D receptor null mice: effect of rescue diet on the developmental changes in renal Na+ -dependent phosphate cotransporters.
Kaneko I; Segawa H; Furutani J; Kuwahara S; Aranami F; Hanabusa E; Tominaga R; Giral H; Caldas Y; Levi M; Kato S; Miyamoto K
Pflugers Arch; 2011 Jan; 461(1):77-90. PubMed ID: 21057807
[TBL] [Abstract][Full Text] [Related]
14. [Fibroblast growth factor 23 mediates the phosphaturic actions of cadmium].
Kido S; Fujihara M; Nomura K; Sasaki S; Shiozaki Y; Segawa H; Tatsumi S; Miyamoto K
Nihon Eiseigaku Zasshi; 2012; 67(4):464-71. PubMed ID: 23095356
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter.
Segawa H; Kawakami E; Kaneko I; Kuwahata M; Ito M; Kusano K; Saito H; Fukushima N; Miyamoto K
Pflugers Arch; 2003 Aug; 446(5):585-92. PubMed ID: 12851820
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23.
Perwad F; Portale AA
Mol Cell Endocrinol; 2011 Dec; 347(1-2):17-24. PubMed ID: 21914460
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice.
Ranch D; Zhang MY; Portale AA; Perwad F
J Bone Miner Res; 2011 Aug; 26(8):1883-90. PubMed ID: 21472778
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c.
Tenenhouse HS; Martel J; Gauthier C; Segawa H; Miyamoto K
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1271-8. PubMed ID: 12952859
[TBL] [Abstract][Full Text] [Related]
19. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
Li H; Martin A; David V; Quarles LD
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.
Nakatani T; Ohnishi M; Razzaque MS
FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
